EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect
Creatinina e funzione renale. Domande e risposte.
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies | Oncogene
eGFR alto, basso e valori normali
Piezo1 activates noncanonical EGFR endocytosis and signaling | Science Advances
Genetic alterations shaping tumor response to anti-EGFR therapies - ScienceDirect
Cancers | Free Full-Text | Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression
Kidney function trajectory in BBS subjects. (A) eGFR declines with age... | Download Scientific Diagram
EGFR blockade promotes morphological and functional rec | Open-i
Frontiers | Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components | Science Translational Medicine
EGFR signaling is critical for macrophage activation and function. (A)... | Download Scientific Diagram
Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy | Journal of Medicinal Chemistry
Full article: Synthesis, characterization and preliminary biological evaluation of chrysin amino acid derivatives that induce apoptosis and EGFR downregulation
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors | Journal of Medicinal Chemistry
Understanding resistance to EGFR inhibitors—impact on future treatment strategies | Nature Reviews Clinical Oncology
Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries | Molecular Pharmacology
EGFR inhibition led ROCK activation enhances desmosome assembly and cohesion in cardiomyocytes | bioRxiv
mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme | SpringerLink
Materials | Free Full-Text | Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
ERBB receptors and cancer: the complexity of targeted inhibitors | Nature Reviews Cancer
Cetuximab–Polymersome–Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers | Biomacromolecules
